Lucid

127 Articles
Created: 2026/06/12 09:32
Updated: 2026/06/12 09:32
Quantum BioPharma Advances Novel MS Therapy Targeting Myelin Repair into Phase 2 Trials

Quantum BioPharma Advances Novel MS Therapy Targeting Myelin Repair into Phase 2 Trials

Quantum BioPharma's Lucid-MS enters phase 2 trials to halt multiple sclerosis progression. Learn how this novel therapy targets myelin repair, offering hope for

Author: Citybuzz
Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis

Quantum BioPharma advances Lucid-MS, a first-in-class drug for multiple sclerosis that protects myelin. Phase 2 trial preparation underway after successful safety

Author: Citybuzz
Tesla Declines 5% While Lucid and Rivian Hold Steady: What’s Going On With EV Stocks Today?

Tesla Declines 5% While Lucid and Rivian Hold Steady: What’s Going On With EV Stocks Today?

Tesla (NASDAQ:TSLA) stock is having a difficult session, falling 5% to $383 even as other electric vehicle (EV) names are showing far more resilience. Meanwhile

Author: 247 Wall St.
Quantum BioPharma’s Lucid-MS Candidate Highlighted for Potential to Address Unmet Need in Multiple Sclerosis Treatment

Quantum BioPharma’s Lucid-MS Candidate Highlighted for Potential to Address Unmet Need in Multiple Sclerosis Treatment

Quantum BioPharma (QNTM) advances Lucid-MS, a first-in-class MS therapy targeting myelin repair, into Phase 2 trials. Learn how this innovative approach could transform

Author: Citybuzz
Lucid (LCID) Stock Tumbles as EV Maker Slashes Workforce by 18% in Latest Restructuring

Lucid (LCID) Stock Tumbles as EV Maker Slashes Workforce by 18% in Latest Restructuring

Lucid (LCID) stock declined 3.6% after announcing 18% workforce cuts, COO exit, and suspended 2026 production guidance in second layoff round this year. The post

Author: Blockonomi
Lucid (LCID) Stock Drops After Second U.S. Layoff Round in 2026

Lucid (LCID) Stock Drops After Second U.S. Layoff Round in 2026

TLDR Lucid is cutting ~18% of its U.S. workforce, covering full-time employees, contractors, and hourly production workers The cuts are expected to save approximately

Author: Coincentral
Quantum BioPharma Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

Quantum BioPharma Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

Quantum BioPharma (NASDAQ: QNTM) advances Lucid-MS, a first-in-class neuroprotective drug for multiple sclerosis, entering Phase 2 trials after promising preclinical

Author: Citybuzz
Quantum BioPharma’s Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Preparing for Phase 2 Trials

Quantum BioPharma’s Lucid-MS Targets Myelin Repair in Multiple Sclerosis, Preparing for Phase 2 Trials

Quantum BioPharma's Lucid-MS, a patented drug candidate targeting myelin repair, enters phase 2 trials for MS. Learn how this novel approach could halt disease

Author: Citybuzz
Wall Street expects Tesla rival to surge 90% despite cash crunch

Wall Street expects Tesla rival to surge 90% despite cash crunch

Lucid CEO expects the partnership with Uber to fuel growth

Author: Thestreet
Microsoft Warns of USB-Based “Crypto Clipper” Malware Spread

Microsoft Warns of USB-Based “Crypto Clipper” Malware Spread

Microsoft Threat Intelligence has issued a warning to Windows users about a cryptocurrency clipper malware strain that spreads through USB drives and has been active

Author: Crypto Breaking News